VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Krystal Biotech, Inc. (KRYS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $9.0B · P/E 41.4 · revenue $470M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows